首页> 美国卫生研究院文献>Journal of the Endocrine Society >MON-615 Retrospective Analysis of the Contribution of Cannabis Usage to Diabetic Ketoacidosis at an Urban Teaching Hospital
【2h】

MON-615 Retrospective Analysis of the Contribution of Cannabis Usage to Diabetic Ketoacidosis at an Urban Teaching Hospital

机译:MON-615回顾性分析大麻用量对城市教学医院糖尿病酮症症的贡献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic ketoacidosis (DKA) is an acute life-threatening complication of diabetes mellitus. It is responsible for greater than 100,000 hospital admissions per year in the US (1). There are few studies regarding the relationship between drug usage and acute diabetic complications (2). Since 2001, cannabis usage among US adults have more than doubled, as state legal restrictions have eased and attitudes towards cannabis have become more permissive. Cannabis is the most commonly used illicit drug in the US (3). Some studies suggested cannabis usage was associated with improvement in insulin sensitivity and pancreatic beta cell function. Other research demonstrated cannabis usage may contribute to diabetes-related hospitalizations.
机译:糖尿病酮症症(DKA)是一种急性生命危及糖尿病的危及危及危及症状的复杂性。它负责美国每年大于100,000名医院入院(1)。关于药物使用与急性糖尿病并发症之间的关系很少有研究(2)。自2001年以来,美国成年人的大麻用量增加了一倍多,因为国家法律限制已经缓解和对大麻的态度变得更加宽松。大麻是美国最常用的非法药物(3)。一些研究表明大麻用量与胰岛素敏感性和胰腺β细胞功能的改善有关。其他研究表明大麻用法可能导致糖尿病相关的住院治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号